List of insiders holdings for Outlook Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Pillai Arun Kumar Director 10% Owner |
2022-02-01 17:09:01 | 0 25,482,529 |
25,482,529 | Form 4 |
| 2 | BioLexis Pte Ltd. 10% Owner |
2024-01-31 16:01:44 | 16,637,024 0 |
16,637,024 | Form 13D |
| 3 | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner |
2025-03-12 21:11:16 | 16,183,787 0 |
16,183,787 | Form 13D |
| 4 | Mohan Pankaj Director 10% Owner |
2019-01-17 16:45:42 | 7,064,553 619,114 |
7,683,667 | Form 4 |
| 5 | Syntone Ventures LLC 10% Owner |
2024-04-17 21:38:26 | 2,776,867 0 |
2,776,867 | Form 13D |
| 6 | Dagnon Terry Chief Operations Officer |
2023-04-21 21:05:47 | 653,058 0 |
653,058 | Form 4 |
| 7 | Bahrt Kenneth Chief Medical Officer |
2019-02-19 20:23:56 | 600,000 0 |
600,000 | Form 4 |
| 8 | TRENARY C RUSSELL III CEO AND PRESIDENT |
2024-03-22 17:00:28 | 455,000 0 |
455,000 | Form 4 |
| 9 | Haddadin Yezan Munther Director |
2024-10-03 20:30:10 | 208,700 0 |
208,700 | Form 4 |
| 10 | MCANDREW STEPHEN J SVP Bus. Strat. & Dev. |
2018-10-24 17:02:13 | 200,000 0 |
200,000 | Form 4 |
| 11 | HILZINGER KURT J Director |
2024-10-03 20:30:07 | 180,459 0 |
180,459 | Form 4 |
| 12 | THURMAN RANDY H Director |
2024-10-03 20:30:05 | 146,185 0 |
146,185 | Form 4 |
| 13 | Griffith Donald J. Director |
2016-11-28 21:59:48 | 144,926 0 |
144,926 | Form 4 |
| 14 | Windisch Joerg Director |
2018-11-13 16:57:57 | 130,465 0 |
130,465 | Form 4 |
| 15 | Gangolli Julian S Director |
2024-10-03 21:22:40 | 127,805 0 |
127,805 | Form 4 |
| 16 | Gangloff Scott A. SVP, Development & Mfrg |
2016-12-22 18:01:49 | 118,573 0 |
118,573 | Form 4 |
| 17 | Haller Julia A Director |
2024-10-03 20:30:18 | 115,950 0 |
115,950 | Form 4 |
| 18 | Auffarth Gerd Director |
2024-10-03 20:30:14 | 98,211 0 |
98,211 | Form 4 |
| 19 | Huang Andong Director |
2024-10-03 20:30:16 | 91,129 0 |
91,129 | Form 4 |
| 20 | Bao Kogan VP, Analytical Sciences |
2016-12-22 18:00:00 | 71,739 0 |
71,739 | Form 4 |
| 21 | Yamashita Elizabeth A. VP, Regulatory Affairs |
2017-12-26 17:07:26 | 64,648 0 |
64,648 | Form 4 |
| 22 | Thomas Joe Director |
2019-10-07 18:10:53 | 63,207 0 |
63,207 | Form 4 |
| 23 | Albrecht Claudio Director |
2017-11-02 18:13:52 | 25,000 0 |
25,000 | Form 4 |
| 24 | Evanson Jeff CHIEF COMMERCIAL OFFICER |
2024-03-22 17:00:24 | 25,000 0 |
25,000 | Form 4 |
| 25 | Brady Todd C Director |
2017-10-30 18:03:52 | 15,000 0 |
15,000 | Form 4 |
| 26 | Canute Scott A Director |
2017-10-30 18:02:53 | 15,000 0 |
15,000 | Form 4 |
| 27 | Dyrness Albert D. Director |
2017-10-30 18:01:52 | 15,000 0 |
15,000 | Form 4 |
| 28 | Sukhtian Faisal Ghiath Director |
2025-02-06 16:40:17 | 12,323 0 |
12,323 | Form 4 |
| 29 | KENYON LAWRENCE A Chief Financial Officer |
2024-09-30 16:53:23 | 5,946 0 |
5,946 | Form 4 |
| 30 | Smith Hoke Robin Director |
2016-11-30 17:27:28 | 5,138 0 |
5,138 | Form 4 |